Selected article for: "control treatment and general population"
Author: Tang, Bin; Li, Sijia; Xiong, Yuwan; Tian, Ming; Yu, Jianbin; Xu, Lixia; Zhang, Li; Li, Zhuo; Ma, Jianchao; Wen, Feng; Feng, Zhonglin; Liang, Xinling; Shi, Wei; Liu, Shuangxin
Title: Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient
  • Cord-id: nxfr24sp
  • Document date: 2020_3_12
    • ID: nxfr24sp
    Snippet: Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). Previous studies of the COVID-19 pneumonia outbreak were based on information from the general population. Limited data are available for hemodialysis patients with COVID-19 pneumonia. This report describes the clinical characteristics of COVID-19 in an in-center hemodialysis patient, as well as our experience in implementing steps to prevent the spr
    Document: Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). Previous studies of the COVID-19 pneumonia outbreak were based on information from the general population. Limited data are available for hemodialysis patients with COVID-19 pneumonia. This report describes the clinical characteristics of COVID-19 in an in-center hemodialysis patient, as well as our experience in implementing steps to prevent the spread of COVID-19 pneumonia among in-center hemodialysis patients. The diagnosis, infection control, and treatment of COVID-19 in hemodialysis patients are discussed in this report, and we conclude with recommendations for how a dialysis facility can respond to COVID-19 based on our experiences.

    Search related documents:
    Co phrase search for related documents
    • acid nucleic and acute illness: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acid nucleic and liu correspondence: 1
    • acid nucleic and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acid nucleic and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid nucleic and lopinavir ritonavir therapy: 1
    • acid nucleic and lung respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • acid nucleic and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid nucleic and lymphocyte white blood cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acid nucleic and lymphopenia common: 1
    • acid test result and lopinavir ritonavir: 1
    • acid test result and lymphocyte count: 1
    • acid testing and acute illness: 1, 2, 3, 4
    • acid testing and liver function: 1, 2, 3
    • acid testing and lopinavir ritonavir: 1, 2, 3, 4
    • acid testing and lung respiratory: 1, 2, 3
    • acid testing and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acid testing and lymphocyte white blood cell: 1, 2, 3, 4, 5, 6
    • acid testing and lymphopenia common: 1
    • active ingredient and lopinavir ritonavir: 1